Loading...
Loading...
By Adriana Alarcón - Thu, 09/25/2025 - 12:40
Mexico’s pharma industry blames debts and Birmex bottlenecks for supply delays, as the government pushes Plan México to boost local production.
Featured content
Thu, 03/19/2026 - 07:00
Mexico leads Latin American medical device exports, leveraging USMCA and nearshoring for strategic economic growth, writes Carlos Alejandro Salazar.
Partnership Content
